Skip to main content
. 2019 Oct 26;20:608. doi: 10.1186/s13063-019-3655-2

Table 1.

Baseline sample characteristics

Variable Total (n = 60) Li/VPA (n = 33) Li/CBZ (n = 27) P value
Female, n (%) 40 (66.7%) 26 (78.8%) 14 (51.8%) 0.05 *
Age, mean (standard deviation (SD), range) 27.8 (5.1, 18–35) 27.5 (4.7, 18–35) 28.3 (5.7, 18–33) 0.57 **
Age at illness onset, mean (SD, range) 20.4 (6.9, 5–35) 20.0 (7.1, 5–30) 20.9 (6.7, 13–5) 0.72 **
Weight in kg, mean (SD) 71.3 (14.4) 73.2 (14.1)) 0.09 *
Current mood, n (%)
 Depression 27 (45.0%) 13 (39.4%) 14 (51.9%) 0.57 **
 Mania/hypomania 17 (28.3%) 11 (33.3%) 6 (22.2%)
 Mixed state 16 (26.7%) 9 (27.3%) 7 (25.9%)
Clinical Global Impressions Scale modified for use in BP, mean (SD, range)
 Overall 3.8 (1.1, 1.0–6.0) 3.8 (1.1, 2.0–6.0) 3.8 (1.0, 1.0–6.0) 0.84 **
 Depression 3.3 (1.6, 0.0–6.0) 3.2 (1.5, 0.0–6.0) 3.4 (1.8, 0.0–6.0) 0.62 **
 Mania/hypomania 2.8 (1.6, 1.0–6.0) 3.2 (1.7, 1.0–6.0) 2.4 (1.3, 1.0–5.0) 0.07 **
Manic symptoms (Young Mania Rating Scale) scores, mean (SD, range) 20.4 (7.2) (5.0–39.0) 19.3 (7.1, 8.0–35.0) 21.6 (7.3, 5.0–39.0) 0.22 **
Depressive symptoms (Hamilton Depression Rating Scale), mean (SD, range) 11.3 (5.9, 2.0–28.0) 11.5 (6.0, 2.0–24.0) 11.1 (5.9, 4.0–28.0) 0.81 **

Li/VPA: lithium plus valproic acid group

Li/CBZ: lithium plus carbamazepine group

*Determined by the Fisher exact test.

**Determined by the student t test.